The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Imaging-based patient inclusion model for clinical trial performance optimization.
 
Michal R Tomaszewski
No Relationships to Disclose
 
Shuxuan Fan
No Relationships to Disclose
 
Jin Qi
No Relationships to Disclose
 
Alberto Garcia
No Relationships to Disclose
 
Youngchul Kim
No Relationships to Disclose
 
Matthew B. Schabath
No Relationships to Disclose
 
Robert A Gatenby
No Relationships to Disclose
 
William D. Tap
Leadership - Atropos; Certis Oncology Solutions; Innovo Therapeutics
Stock and Other Ownership Interests - Atropos; Certis Oncology Solutions
Consulting or Advisory Role - AbMaxBio; Adcendo; Agios; Ayala Pharmaceuticals; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; EMD Serono; Kowa Pharmaceutical; Lilly; Mundipharma; NanoCarrier; Servier
Research Funding - BioAtla; Blueprint Medicines; Daiichi Sankyo; Deciphera; Immune Design; Lilly; Novartis; Plexxikon; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Companion Diagnostic for CDK4 inhibitors - 14/854,329; Enigma and CDH18 as companion Diagnostics for CDK4 inhibition – SKI2016-021-03
 
Denise K. Reinke
Research Funding - SARC: Sarcoma Alliance for Research though Collaboration (Inst)
 
Rikesh J Makanji
No Relationships to Disclose
 
Damon R. Reed
Consulting or Advisory Role - Eisai; Pfizer
Travel, Accommodations, Expenses - Salarius Pharmaceuticals
 
Robert J Gillies
Stock and Other Ownership Interests - HealthMyne
Consulting or Advisory Role - HealthMyne
Research Funding - Helix BioPharma